Skip to main content
. 2014 Nov;50(16):2763–2770. doi: 10.1016/j.ejca.2014.08.002

Table 8.

Factors influencing chemotherapy use in patients in whom Oncotype Dx was not used.

Factor Significance OR
Interval 0.045
 Oncotype available on trial only 0.069 0.45
 Oncotype not publicly reimbursed 0.121 0.42
 Oncotype routinely used 0.008 0.09
Grade 0.001
 Grade 2 0.002 9.20
 Grade 3 <0.0001 17.72
Size 0.03 1.06
Age <0.0001 0.84

Compared to interval prior to availability of Oncotype DX.

Compared to grade I.